Assessing the Use of Wearable Activity Trackers in a Pregnancy Cohort

by palligoelme@gmail.com | Jan 12, 2026 | Clinical Trials

​ Conditions: Pregnancy Related Interventions: Device: Wearable Activity Tracker Sponsors: Oregon Health and Science University Not yet recruiting Conditions: Pregnancy Related Interventions: Device: Wearable Activity Tracker Sponsors: Oregon Health and Science...

Impact of Pilates Exercises on Osteoporosis in Breast Cancer Survivors Receiving Hormonal Therapy

by palligoelme@gmail.com | Jan 12, 2026 | Clinical Trials

​ Conditions: Breast Cancer; Breast Cancer Survivors; Aromatase Inhibitors; Osteoporosis or Osteopenia; Pilates Exercise Interventions: Other: Pilates Exercises; Drug: Calcium and Vitamin D Supplementation Sponsors: Benha University; Beni-Suef University Not yet...

Wearable Devices for Early Detection of Postoperative Infection

by palligoelme@gmail.com | Jan 12, 2026 | Clinical Trials

​ Conditions: Wearable Devices Interventions: Diagnostic Test: White Blood Cell (WBC); Diagnostic Test: C-reactive Protein (CRP) Sponsors: Benha University Completed Conditions: Wearable Devices Interventions: Diagnostic Test: White Blood Cell (WBC); Diagnostic Test:...

The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastectomy

by palligoelme@gmail.com | Jan 12, 2026 | Clinical Trials

​ Conditions: Breast Cancer; Breast Reconstruction Interventions: Procedure: Fat grafting combined with latissimus dorsi muscle flap Sponsors: Sohag University Recruiting Conditions: Breast Cancer; Breast Reconstruction Interventions: Procedure: Fat grafting combined...

Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

by palligoelme@gmail.com | Jan 12, 2026 | Clinical Trials

​ Conditions: Metabolic Dysfunction-Associated Steatohepatitis(MASH) Interventions: Drug: QL2401; Drug: Placebo Sponsors: Qilu Pharmaceutical Co., Ltd. Not yet recruiting Conditions: Metabolic Dysfunction-Associated Steatohepatitis(MASH) Interventions: Drug: QL2401;...